Efficacy of Jia Wei Shoutai Wan Combined With Dydrogesterone in the Treatment of Threatened Abortion Complicated With Endometrial Cavity Fluid: A Prospective, Single-Center, Randomized Controlled Trial.

Yongrong Zhang, Huan Wei, Hui Li, Yu Zhang, Fang Jia

Abstract read

In one paragraph

Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Efficacy of Jia Wei Shoutai Wan Combined With Dydrogesterone in the Treatment of Threatened Abortion Complicated With Endometrial Cavity Fluid: A Prospective, Single-Center, Randomized Controlled Trial.International journal of endocrinology · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yongrong ZhangObstetrics and Gynecology Department, Mianyang Maternal and Child Health-Care Hospital, Mianyang, 621000, Sichuan, China, scu.edu.cn.ORCID https://orcid.org/0009-0004-3059-8389

Huan WeiObstetrics and Gynecology Department, Mianyang Maternal and Child Health-Care Hospital, Mianyang, 621000, Sichuan, China, scu.edu.cn.ORCID https://orcid.org/0009-0002-0383-2622

Hui LiDepartment of Traditional Chinese Medicine, Mianyang Maternal and Child Health-Care Hospital, Mianyang, 621000, Sichuan, China, scu.edu.cn.ORCID https://orcid.org/0009-0005-3434-9299

Yu ZhangDepartment of Traditional Chinese Medicine, Mianyang Maternal and Child Health-Care Hospital, Mianyang, 621000, Sichuan, China, scu.edu.cn.ORCID https://orcid.org/0009-0001-7294-9253

Fang JiaObstetrics and Gynecology Department, Mianyang Maternal and Child Health-Care Hospital, Mianyang, 621000, Sichuan, China, scu.edu.cn.ORCID https://orcid.org/0009-0007-2757-6703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to evaluate the clinical efficacy of Jia Wei Shoutai Wan (JWSTW) combined with dydrogesterone in patients with threatened abortion (TA) complicated by endometrial cavity fluid (ECF). Methods: This was a prospective, single-center, randomized controlled trial. A total of 130 patients with TA and ECF admitted to our hospital from January to November 2022 were screened. Thirteen patients did not meet the inclusion criteria, and five refused to participate, leaving 112 eligible participants. Using a random number table, patients were assigned to a control group (dydrogesterone alone, Results: After treatment, the combination group showed significantly lower TCM symptom scores and a smaller ECF area ( Conclusion: JWSTW combined with dydrogesterone may be beneficial for treating TA with ECF by improving clinical symptoms, optimizing hormone and coagulation profiles, and reducing ECF without increasing adverse reactions.

Indexed as

abortionChinese traditionaldydrogesteronemedicinethreatenedtreatment outcomeuterine diseases

Identifiers

PMID41948094

DOI10.1155/ije/5226490

PMCPMC13051817

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.